×
About 63 results

ALLMedicine™ Acute Myelomonocytic Leukemia Center

Research & Reviews  23 results

Pure erythroid leukemia subsequent to acute myelomonocytic leukemia: A case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052012
Medicine Ji J, Li Y et. al.

Apr 14th, 2021 - Pure erythroid leukemia is a rare subcategory of acute myeloid leukemia characterized by predominant immature erythroid population. Its occurrence subsequent to acute myelomonocytic leukemia has not been reported before. We reported this rare case...

Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal...
https://doi.org/10.21873/anticanres.14488
Anticancer Research; Thadi A, Lewis L et. al.

Sep 4th, 2020 - Anticancer peptide PNC-27 binds to HDM-2 protein on cancer cell membranes inducing the formation of cytotoxic transmembrane pores. Herein, we investigated HDM-2 membrane expression and the effect of PNC-27 treatment on human non-stem cell acute my...

LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921214
Molecular Cancer Therapeutics; Anami Y, Deng M et. al.

Sep 4th, 2020 - Acute myeloid leukemia (AML) is the most common and aggressive blood cancer in adults. In particular, significant unmet medical needs exist for effective treatment strategies for acute myelomonocytic leukemia (M4) and acute monocytic leukemia (M5)...

Pathology of Acute Myeloid Leukemia Not Otherwise Specified (AML NOS)
https://emedicine.medscape.com/article/1977919-print

Jul 21st, 2020 - In the 2016 update to the 2008 World Health Organization (WHO) classification system,[1, 2] the category "acute myeloid leukemia [AML] not otherwise specified" [NOS])" excludes AML subtypes associated with recurrent genetic abnormalities such as: ...

see more →

News  2 results

Leukemia Cutis–Associated Leonine Facies and Eyebrow Loss
https://www.mdedge.com/dermatology/article/198141/nonmelanoma-skin-cancer/leukemia-cutis-associated-leonine-facies-and
Philip R. Cohen, MD

Apr 3rd, 2019 - To the Editor: I read with interest the informative Cutis case report by Krooks and Weatherall1 in which the authors not only described the case of a 66-year-old man whose diagnosis of bone marrow biopsy–confirmed acute myeloid leukemia (AML) pres.

Antilymphocyte globulin curbs chronic graft-versus-host disease
https://www.mdedge.com/internalmedicine/article/105685/t-cell-lymphomas/antilymphocyte-globulin-curbs-chronic-graft-versus
Jennifer Shepphird

Jan 9th, 2016 - Antilymphocyte globulin (ATG) added to the myeloablative conditioning regimen of patients undergoing allogeneic stem cell transplantation resulted in a lower incidence of chronic graft-versus-host disease (GVHD) compared with conditioning regimens.

see more →